https://european-biotechnology.net/wp-content/uploads/2024/09/STEP-2-1-5-e1726737997871.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-19 09:27:312024-09-19 09:27:31French Brenus AS closes US$25m financing
https://european-biotechnology.net/wp-content/uploads/2024/09/324EB_von-der-Leyen_tg-1030x687-1.webp
687
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-18 09:20:452024-09-26 16:32:01Von der Leyen names new EU Commissioners
https://european-biotechnology.net/wp-content/uploads/2024/09/ImmunOS.png
404
748
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-17 13:17:552024-09-17 13:17:55ImmunOs Therapeutics AG raises US$11m in Series C financing
https://european-biotechnology.net/wp-content/uploads/2024/09/Richter-Biologics-red-tape-e1726401635512-1030x580-1.png
580
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-15 12:10:432024-09-15 12:10:43Richter-Helm Biologics triples production capacity
https://european-biotechnology.net/wp-content/uploads/2024/09/phoremost-team-e1726068886775.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-11 16:01:552024-09-11 16:01:55Phoremost reports Series B extension
https://european-biotechnology.net/wp-content/uploads/2024/09/SOLASTA-Bio-laboratory-002-pic-credit-Andrew-Cawley-1030x579-1.jpg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-11 14:29:292024-09-11 14:29:29Funding for green insecticides
https://european-biotechnology.net/wp-content/uploads/2024/09/az-gothenburg-1030x579-1.jpeg
579
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-10 14:05:592024-09-10 14:05:59AZ’s lung cancer drug disappoints
https://european-biotechnology.net/wp-content/uploads/2024/09/Epsilogen.jpg
440
780
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-09 13:10:562024-09-09 13:10:56Epsilogen Ltd completes £12.5m Series B expansion
https://european-biotechnology.net/wp-content/uploads/2024/09/Haya-Team.png
448
614
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-04 17:17:362024-09-04 17:17:36Swiss RNA maker Haya in huge licence deal
https://european-biotechnology.net/wp-content/uploads/2024/09/Fenebrutinib-wikimedia.org_-e1725436453119.png
450
800
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2024-09-04 07:54:452024-09-04 07:54:45Roche with good interim clinical results
Scroll to top
